Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × aumolertinib × Thoracic × Clear all

Phase

Phase 2 17 Phase 3 12 Phase 1 3 Phase NA 2 Phase 2/3 2 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Adenocarcinoma 1

Interventions

Cisplatin 15 Pemetrexed 13 Erlotinib Hydrochloride 13 Carboplatin 12 icotinib 8 Propofol 6 Gefitinib 6 Docetaxel 6 endostar protein 5 Saline Solution 5 Endostatins 5 lorlatinib 4 anlotinib 4 Nivolumab 4 Gemcitabine 4 Drug Therapy 4 Afatinib 4 tislelizumab 3 pembrolizumab 3 durvalumab 3 Zoledronic Acid 3 Vinorelbine 3 Sevoflurane 3 Radiotherapy 3 Paclitaxel 3 Dexamethasone 3 Acetaminophen 3 trilaciclib 2 pegfilgrastim 2 osimertinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04401059 2023-12-27

SELECT-2

Hangzhou Normal University

Phase 4 Recruiting

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡